RBC Europe’s bluebird bio BLUE Stock Holding History

RBC Europe’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20	Closed	-$5.06K	–	696
2021 Q3	$5.06K	Hold	20	–	–	﹤0.01%	1043
2021 Q2	$8.47K	Hold	20	–	–	﹤0.01%	985
2021 Q1	$7.99K	Hold	20	–	–	﹤0.01%	947
2020 Q4	$11.5K	Hold	20	–	–	﹤0.01%	853
2020 Q3	$14.3K	Buy	20 +15	+300%	+$11.7K	﹤0.01%	722
2020 Q2	$3.97K	Hold	5	–	–	﹤0.01%	893
2020 Q1	$2.99K	Hold	5	–	–	﹤0.01%	875
2019 Q4	$5.7K	Hold	5	–	–	﹤0.01%	895
2019 Q3	$5.97K	Hold	5	–	–	﹤0.01%	874
2019 Q2	$8.27K	Hold	5	–	–	﹤0.01%	837
2019 Q1	$10.2K	Hold	5	–	–	﹤0.01%	811
2018 Q4	$6.45K	Hold	5	–	–	﹤0.01%	881
2018 Q3	$9.49K	Hold	5	–	–	﹤0.01%	861
2018 Q2	$10.2K	Hold	5	–	–	﹤0.01%	857
2018 Q1	$11.1K	Buy	+5	New	+$12.7K	﹤0.01%	814

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RBC Europe's BLUE Position: Q4 2021 in Review

RBC Europe sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 20 shares — an estimated $5.06K sold.

RBC Europe first reported a position in BLUE in Q1 2018 and held it in 15 quarters. The position peaked at $14.3K in Q3 2020. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

RBC Europe reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 20 bluebird bio shares in Q4 2021, an estimated $5.06K.
RBC Europe first reported a position in bluebird bio in Q1 2018 and held it in 15 quarters.
RBC Europe's bluebird bio position peaked at $14.3K in Q3 2020.
172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.